Medical Oncology

Nicholas Christian DeVito, MD

Medical Instructor in the Department of Medicine
Member of the Duke Cancer Institute
Campus mail DUMC Box 3052, Durham, NC 27710
Email address nicholas.devito@duke.edu

I am an instructor of Medical Oncology who primarily treats patients with gastrointestinal malignancies. My laboratory and translational research is focused on tumor immune evasion and immunotherapy, with a specific interest in dendritic cell tolerance.

Education and Training

  • Hematology-Oncology Fellowship, Medicine, Duke University School of Medicine, 2015 - 2018
  • Internal Medicine Internship and Residency, Tufts University School of Medicine, 2012 - 2015
  • M.D., University of South Florida, College of Medicine, 2012

Grants

Publications

Plebanek, Michael, Nicholas DeVito, Fang Liu, Balamayooran Theivanthiran, Georgia Beasley, and Brent Hanks. “657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway.” In Journal for Immunotherapy of Cancer, 9:A685–A685. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.657.

Full Text

Theivanthiran, Balamayooran, Fang Liu, Nicholas DeVito, Michael Plebanek, and Brent Hanks. “319 The tumor-intrinsic NLRP3 inflammasome establishes a pulmonary metastatic niche via type II epithelial HSP70/TLR4 signaling and facilitates disease hyperprogression in response to immunotherapy.” In Journal for Immunotherapy of Cancer, 9:A343–A343. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.319.

Full Text

DeVito, Nicholas, Michael Sturdivant, Balamayooran Theivanthiran, Y-Van Nguyen, Michael Plebanek, and Brent Hanks. “923 Hedgehog signaling drives epithelial-to-mesenchymal transition, immune evasion, and anti-PD-1 resistance through coordinated upregulation of Wnt ligands and PGE2 synthesis.” In Journal for Immunotherapy of Cancer, 9:A968–A968. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.923.

Full Text

Theivanthiran, Balamayooran, Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael Plebanek, Nicholas C. DeVito, and Brent A. Hanks. “Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.” Cancers (Basel) 13, no. 19 (September 23, 2021). https://doi.org/10.3390/cancers13194753.

PMID
34638239
Full Text

Sammons, Sarah, Andrew Elliott, Jeremy Meyer Force, Nicholas C. DeVito, Paul Kelly Marcom, Sandra M. Swain, Antoinette R. Tan, et al. “Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features.” In Journal of Clinical Oncology, 39:1091–1091. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.15_suppl.1091.

Full Text

DeVito, Nicholas C., Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K. S. Salama, Georgia M. Beasley, et al. “Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.” Cell Rep 35, no. 5 (May 4, 2021): 109071. https://doi.org/10.1016/j.celrep.2021.109071.

PMID
33951424
Full Text

DeVito, Nicholas C., Colm Kelleher, Kyle C. Strickland, James Abbruzzese, Carey Anders, Brent A. Hanks, Jingquan Jia, et al. “A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis.” Ame Case Rep 5 (2021): 14. https://doi.org/10.21037/acr-20-154.

PMID
33912803
Full Text

DeVito, Nicholas, Michael Sturdivant, Luke Wachsmuth, John Strickler, Georgia Beasley, Rami Al-Rohil, April Salama, and Brent Hanks. “425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma.” In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0425.

Full Text

Plebanek, Michael P., Michael Sturdivant, Nicholas C. DeVito, and Brent A. Hanks. “Role of dendritic cell metabolic reprogramming in tumor immune evasion.” Int Immunol 32, no. 7 (June 26, 2020): 485–91. https://doi.org/10.1093/intimm/dxaa036.

PMID
32449776
Full Text

Theivanthiran, Balamayoora, Kathy S. Evans, Nicholas C. DeVito, Michael Plebanek, Michael Sturdivant, Luke P. Wachsmuth, April Ks Salama, et al. “A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.” J Clin Invest 130, no. 5 (May 1, 2020): 2570–86. https://doi.org/10.1172/JCI133055.

PMID
32017708
Full Text

Pages